Mangoceuticals, Inc.

NasdaqCM:MGRX Stock Report

Market Cap: US$5.9m

Mangoceuticals Balance Sheet Health

Financial Health criteria checks 4/6

Mangoceuticals has a total shareholder equity of $13.4M and total debt of $187.5K, which brings its debt-to-equity ratio to 1.4%. Its total assets and total liabilities are $14.8M and $1.4M respectively.

Key information

1.4%

Debt to equity ratio

US$187.50k

Debt

Interest coverage ration/a
CashUS$90.85k
EquityUS$13.39m
Total liabilitiesUS$1.40m
Total assetsUS$14.79m

Recent financial health updates

Recent updates

Financial Position Analysis

Short Term Liabilities: MGRX's short term assets ($104.1K) do not cover its short term liabilities ($1.4M).

Long Term Liabilities: MGRX's short term assets ($104.1K) exceed its long term liabilities ($12.2K).


Debt to Equity History and Analysis

Debt Level: MGRX's net debt to equity ratio (0.7%) is considered satisfactory.

Reducing Debt: Insufficient data to determine if MGRX's debt to equity ratio has reduced over the past 5 years.


Balance Sheet


Cash Runway Analysis

For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.

Stable Cash Runway: MGRX has sufficient cash runway for 0 months based on last reported free cash flow, but has since raised additional capital.

Forecast Cash Runway: MGRX is forecast to have sufficient cash runway for 0 months based on free cash flow estimates, but has since raised additional capital.


Discover healthy companies